Similarly, the present study indicates a dose-dependent inhibition of the anti-apoptotic protein Bcl-2 and a concomitant increase in the expression of the Bax, and p53 proteins by CoQ0 in melanoma cells. The gene discussed is BCL2; the disease is melanoma.